EMAIL THIS PAGE TO A FRIEND

Hypertension research : official journal of the Japanese Society of Hypertension

Valsartan ameliorates the constitutive adipokine expression pattern in mature adipocytes: a role for inverse agonism of the angiotensin II type 1 receptor in obesity.


PMID 24599011

Abstract

Angiotensin (Ang) II receptor blockers (ARBs) alleviate obesity-related insulin resistance, which suggests an important role for the Ang II type 1 receptor (AT1R) in the regulation of adipocytokines. Therefore, we treated mature 3T3-L1 adipocytes with 50 μmol l(-1) of valsartan, a selective AT1R blocker without direct agonism to peroxisome proliferator-activated receptor (PPAR)-γ. In the absence of effective concentrations of Ang II, unstimulated mature adipocytes expressed and secreted high levels of interleukin (IL)-6. This constitutive proinflammatory activity was attenuated by the suppression of extracellular signal-regulated kinase phosphorylation by valsartan but was unaffected by the Ang II type 2 receptor blocker PD123319. COS7 cells co-transfected with AT1R and IL-6, which expressed NF-κB but lacked PPAR-γ, showed no constitutive but substantial ligand-dependent IL-6 reporter activity, which was counteracted by valsartan. Valsartan preserved cytosolic IκB-α and subsequently reduced nuclear NF-κB1 protein expression in mature adipocytes. Interestingly, valsartan did not increase PPAR-γ messenger RNA expression per se but enhanced the transcriptional activity of PPAR-γ in mature adipocytes; this enhancement was accompanied by upregulation of the PPAR coactivator (PGC)-1α. Moreover, T0090907, a PPAR-γ inhibitor, increased IL-6 expression, and this increase was attenuated by valsartan. Indeed, addition of valsartan without direct PPAR-γ agonism increased adiponectin production in mature adipocytes. Together, the findings indicate that valsartan blocks the constitutive AT1R activity involving the NF-κB pathway that limits PPAR-γ activity in mature adipocytes. Thus, inverse agonism of AT1R attenuates the spontaneous proinflammatory response and enhances the constitutive insulin-sensitizing activities of mature adipocytes, which may underlie the beneficial metabolic impacts of ARBs.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

HPA021289
Anti-BBS9 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1408674
Anti-BBS9 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB4501766
Anti-Lamin A (Cleaved-Asp230) antibody produced in rabbit, affinity isolated antibody
SAB4501767
Anti-Lamin A (Cleaved-Asp230) antibody produced in rabbit, affinity isolated antibody
SAB4501764
Anti-Lamin A antibody produced in rabbit, affinity isolated antibody
SAB1406087
Anti-LMNA antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA006660
Anti-LMNA antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4300493
Anti-MAPK3 (Ab-202) antibody produced in rabbit, affinity isolated antibody
SAB4300494
Anti-MAPK3 (Ab-204) antibody produced in rabbit, affinity isolated antibody
GW22781 Anti-MAPK3 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB1412386
ANTI-MAPK3 antibody produced in mouse, clone 1E2, purified immunoglobulin, buffered aqueous solution
SAB2701851
Anti-mapk3 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2701770
Anti-mapk3 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA003995
Anti-MAPK3 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA005700
Anti-MAPK3 antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2104574
Anti-MAPK3 antibody produced in rabbit, affinity isolated antibody
SAB2104732
Anti-MAPK3 antibody produced in rabbit, affinity isolated antibody
M3946 Anti-MNK1 antibody produced in rabbit, ~1.4 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4503422
Anti-MNK1 antibody produced in rabbit, affinity isolated antibody
SAB4503423
Anti-MNK1 antibody produced in rabbit, affinity isolated antibody
SAB1405580
Anti-MS4A1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA014341
Anti-MS4A1 antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA014391
Anti-MS4A1 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4501989
Anti-NF-κB p105 antibody produced in rabbit, affinity isolated antibody
SAB2501861
Anti-NFASC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
HPA008832
Anti-NFASC antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4300301
Anti-NFKB1 (Ab-337) antibody produced in rabbit, affinity isolated antibody
SAB4300302
Anti-NFKB1 (Ab-893) antibody produced in rabbit, affinity isolated antibody
SAB4300303
Anti-NFKB1 (Ab-907) antibody produced in rabbit, affinity isolated antibody
SAB4300554
Anti-NFKB1 (Ab-927) antibody produced in rabbit, affinity isolated antibody